International Journal of Advances in Pharmaceutics https://ssjournals.com/index.php/ijap <p align="justify"><strong>International Journal of Advances in Pharmaceutics</strong> (IJAP) is a bi-monthly publication committed to publishing online the original scientific research and reviews in the field of Pharmaceutical Sciences. It mainly covers the articles of special interest, covering the areas of Pharmaceutical research, recent technology &amp; discoveries in the emerging arena of Pharmaceutics and pharmaceutical technology.&nbsp; <strong>Online ISSN:</strong> 2320-4923 |<strong> Print ISSN:</strong> 2320-4931</p> Scholar Science Journals en-US International Journal of Advances in Pharmaceutics 2320-4931 <p>Authors who publish with this journal agree to the following terms:</p> <ol type="a"> <li class="show">Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a&nbsp;<a href="http://creativecommons.org/licenses/by/3.0/" target="_new">Creative Commons Attribution License</a>&nbsp;that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.</li> <li class="show">Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.</li> <li class="show">Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See&nbsp;<a href="http://opcit.eprints.org/oacitation-biblio.html" target="_new">The Effect of Open Access</a>).</li> </ol> Formulation And Development Of Nanosuspension As An Alternative Approach For Solubility And Dissolution Enhancement Of Aceclofenac https://ssjournals.com/index.php/ijap/article/view/4879 <p>Main objectives to develop Aceclofenac Nanosuspension are to enhance solubility and dissolution rate of poorly soluble Drug (aceclofenac), substantially leading to its bioavailability enhancement &amp; Improvement of aqueous and saturation solubility in turn rapid release of Drug which leads to enhancing therapeutic efficacy. Aceclofenac Nanosuspension was prepared by quasi solvent evaporation method with help of different polymer and concentration. There was changes polymer ratio, volume of organic solvent and stirring speed. Aceclofenac nanosuspension gives immediate release. Aceclofenac nanosuspension were showing highest dissolution rate within 10 minutes comparison with marketed formulations. Aceclofenac Nanosuspension compacts may enhance aqueous solubility and dissolution rate in compare to other solubility enhancement technique hence, this research work may be useful to formulate Aceclofenac Nanosuspension which may give rapid onset of action by rapid absorption, maximize efficacy, dose frequency &amp; hence increase patient Compliance.</p> Harshil M Patel Urvashi B. Patel Chainesh Shah Bhavesh Akbari ##submission.copyrightStatement## http://creativecommons.org/licenses/by/4.0 2018-05-31 2018-05-31 7 5 33 47